Work

Abstract PO-219: The implications of genetic ancestry and allostatic load on clinical outcomes in the ECOG-ACRIN adjuvant breast cancer trial E5103

Year: 2022

Type: conference-abstract

Source: Cancer Epidemiology Biomarkers & Prevention

DOI: 10.1158/1538-7755.disp21-po-219

Authors: Samilia Obeng-Gyasi, Anne ONeill, Kathy D. Miller, Bryan P. Schneider, Ann H. Patridge, Lava R. Timsina, George W. Sledge, Lynne Wagner, Ruth C. Carlos

Institutions: The Ohio State University, Dana-Farber Cancer Institute, Indiana University Health, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Dana-Farber/Harvard Cancer Center, Indiana University School of Medicine, Stanford Cancer Institute, Wake Forest University Health Sciences, University of Michigan, U-M Rogel Cancer Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4206759102

Cites:

Cited by: 1

Related to: 10